Jun 30
|
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock
|
Jun 25
|
Bio-Techne, USP Partner to Enhance Monoclonal Antibody, Gene Therapy Development
|
Jun 25
|
Is Bio-Techne Stock Underperforming the Nasdaq?
|
Jun 24
|
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
|
May 30
|
Bio-Techne Corporation (TECH): A Bull Case Theory
|
May 29
|
Is Bio-Techne Stock the Right Pick for Your Portfolio Now?
|
May 29
|
Bio-Techne to Present at Investor Conferences
|
May 26
|
3 Out-of-Favor Stocks Walking a Fine Line
|
Apr 18
|
Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks
|
Apr 18
|
Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)
|
Apr 15
|
Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results
|
Apr 5
|
3 Small-Cap Stocks with Mounting Challenges
|
Apr 2
|
Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
|
Mar 31
|
Bio-Techne Opens New Customer Experience Centre in Germany
|
Mar 31
|
3 Reasons to Avoid TECH and 1 Stock to Buy Instead
|
Feb 24
|
Bio-Techne Stock Set to Benefit From Expansion of RNAscope Menu
|
Feb 20
|
Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
|
Feb 18
|
Bio-Techne's (NASDAQ:TECH) Soft Earnings Don't Show The Whole Picture
|
Feb 18
|
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
|
Feb 6
|
Bio-Techne Corp (TECH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|